Acknowledgements
We thank the patients who generously participated in the GENESIS trial, along with their families and caregivers. We also thank all the members of the treating teams at each participating site including, but not limited to, the nursing, research and support staff for their dedication to patient care and clinical research. Funding: BioLineRx, Ltd.; NIH/NCI R35 CA210084 (J.F.D.) and NIH/NCI R50 CA211466 (M.P.R.).